A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A
NN7442-8454
Phase 1 other active
Quick answer
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A for Haemophilia A with or without inhibitors. Proposed indication under development: prevention of bleeding and long-term prophylaxis in patients with haemophilia A, irrespective of inhibitor status or severity. is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Haemophilia A with or without inhibitors. Proposed indication under development: prevention of bleeding and long-term prophylaxis in patients with haemophilia A, irrespective of inhibitor status or severity.
- Phase
- Phase 1
- Modality
- other
- Status
- active